112 related articles for article (PubMed ID: 2881510)
21. [Critical evaluation of the protracted use of somatostatin in the conservative treatment of complex pancreatico-duodenal fistulas].
Rumi A; Testone G; Uggeri G
Chir Ital; 1983 Dec; 35(6):1003-13. PubMed ID: 6151875
[TBL] [Abstract][Full Text] [Related]
22. [Conservative treatment of fistulas of the pancreas and the small intestine with somatostatin (author's transl)].
Hild P; Stoyanov M; Dobroschke J; Aigner K
Ann Chir; 1982 Mar; 36(3):193-6. PubMed ID: 6124203
[No Abstract] [Full Text] [Related]
23. Administration of somatostatin analog (SMS 201-995) in the treatment of a fistula occurring after pancreas transplantation. Interference with cyclosporine immunosuppression.
Rosenberg L; Dafoe DC; Schwartz R; Campbell DA; Turcotte JG; Tsai ST; Vinik A
Transplantation; 1987 May; 43(5):764-6. PubMed ID: 2883747
[No Abstract] [Full Text] [Related]
24. [500 days of somatostatin treatment].
Fiora U
Minerva Dietol Gastroenterol; 1990; 36(3):171-6. PubMed ID: 1980728
[TBL] [Abstract][Full Text] [Related]
25. Treatment of pancreatic fistula with the somatostatin analogue SMS 201-995.
Ahrén B; Tranberg KG; Bengmark S
Br J Surg; 1988 Jul; 75(7):718. PubMed ID: 2901281
[No Abstract] [Full Text] [Related]
26. Successful treatment of a high-output fistula with a somatostatin analogue following pancreas transplantation.
Cooper MM; Wright FH; Smith JL; Corry RJ
Transplant Proc; 1989 Aug; 21(4):3738-41. PubMed ID: 2474877
[No Abstract] [Full Text] [Related]
27. Failure of somatostatin or an analog to promote closure of end pancreatic fistulae.
Miller BM; Traverso LW; Freeny PC; Abumrad NN
Int J Pancreatol; 1989 Feb; 4(1):65-72. PubMed ID: 2466917
[TBL] [Abstract][Full Text] [Related]
28. [The administration of sandostatin in the combined treatment of acute pancreatitis and its complications].
Saenko VF; Lupal'tsov VI; Babenkov GF; Kopchak VM; Volzhanskiĭ AP
Klin Khir; 1999; (10):5-7. PubMed ID: 10584505
[TBL] [Abstract][Full Text] [Related]
29. Systematic review and meta-analysis of somatostatin analogues for the treatment of pancreatic fistula.
Gans SL; van Westreenen HL; Kiewiet JJ; Rauws EA; Gouma DJ; Boermeester MA
Br J Surg; 2012 Jun; 99(6):754-60. PubMed ID: 22430616
[TBL] [Abstract][Full Text] [Related]
30. [Application of somatulin in the treatment of complications after operations on the pancreatic gland].
Iareshko VG; Mikheev IuA; Krivoruchko IV
Klin Khir; 2009 Jan; (1):23-5. PubMed ID: 19670749
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the effects of two somatostatin analogues in a patient with an external pancreatic fistula.
Heij HA; Bruining HA; Verschoor L
Pancreas; 1986; 1(2):188-90. PubMed ID: 2883648
[TBL] [Abstract][Full Text] [Related]
32. The influence of somatostatin on postoperative outcome after elective pancreatic surgery.
Van Hee R; De Laet I; Salgado R; Ysebaert D
Acta Chir Belg; 1998; 98(2):62-5. PubMed ID: 9615159
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial comparing somatostatin with octreotide in the prevention of complications after pancreatectomy.
Closset J; Journe S; Mboti F; El Nakadi I; Gelin M
Hepatogastroenterology; 2008; 55(86-87):1818-23. PubMed ID: 19102400
[TBL] [Abstract][Full Text] [Related]
34. [Biliary perforations caused by acute pancreatitis: considerations apropos of a case of necrosis of the intrapancreatic choledochus caused by acute cephalopancreatitis secondary to a transduodenal sphincterotomy].
Lago TF; Pandolfi U; Castagnoli L; Braschi A; Fischetti M; Cremaschi E
Chir Ital; 1984 Oct; 36(5):743-59. PubMed ID: 6152735
[TBL] [Abstract][Full Text] [Related]
35. Somatostatin analogues in the prevention of pancreas-related complications after pancreatic resection.
Ramos-De la Medina A; Sarr MG
J Hepatobiliary Pancreat Surg; 2006; 13(3):190-3. PubMed ID: 16708293
[TBL] [Abstract][Full Text] [Related]
36. [Formation of pancreatic sequester as a result of hemorrhagic pancreatitis].
Olszewski K; Muszyński M
Pol Przegl Chir; 1973 Oct; 45(10):1009-11. PubMed ID: 4543652
[No Abstract] [Full Text] [Related]
37. Somatostatin in the management of gastrointestinal fistulas. A multicenter trial.
Torres AJ; Landa JI; Moreno-Azcoita M; Argüello JM; Silecchia G; Castro J; Hernandez-Merlo F; Jover JM; Moreno-Gonzales E; Balibrea JL
Arch Surg; 1992 Jan; 127(1):97-9; discussion 100. PubMed ID: 1346491
[TBL] [Abstract][Full Text] [Related]
38. [Use of octreotide in the treatment of pancreatic fistula].
Zelli GP
Minerva Chir; 1992 Apr; 47(8):735-6. PubMed ID: 1351279
[No Abstract] [Full Text] [Related]
39. [Somatostatin prophylaxis following cephalic duodenopancreatectomy].
Beguiristain A; Espí A; Balen E; Pardo F; Hernández Lizoaín JL; Alvarez Cienfuegos J
Rev Esp Enferm Dig; 1995 Mar; 87(3):221-4. PubMed ID: 7742052
[TBL] [Abstract][Full Text] [Related]
40. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
Martineau P; Shwed JA; Denis R
Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
